Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

63.08
Delayed Data
As of 4:02pm ET
 -1.76 / -2.71%
Today’s Change
50.90
Today|||52-Week Range
132.60
-15.48%
Year-to-Date

Today’s Trading

Previous close64.84
Today’s open64.08
Day’s range61.87 - 64.39
Volume2,600,374
Average volume (3 months)2,545,371
Market cap$7.3B
Dividend yield--
Data as of 4:02pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+9.16%
Earnings growth (next 5 years)+9.33%
Revenue growth (last year)+31.75%
P/E ratio21.9
Price/Sales2.40
Price/Book1.42

Competitors

 Today’s
change
Today’s
% change
IDXXIDEXX Laboratories I...-0.15-0.18%
RDYDr.Reddy's Laborator...-1.32-2.95%
ENDPEndo International P...-0.76-2.70%
ALKSAlkermes Plc-1.58-4.03%
Data as of 4:02pm ET, 05/04/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)$2.01
Annual revenue (last year)$3.3B
Annual profit (last year)$322.1M
Net profit margin9.13%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts

Partner Offers

Search for Jobs